Optimizing Cutoff Scores for the Barthel Index and the Modified Rankin Scale for Defining Outcome in Acute Stroke Trials
Top Cited Papers
- 1 September 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 36 (9) , 1984-1987
- https://doi.org/10.1161/01.str.0000177872.87960.61
Abstract
Background and Purpose— There is little agreement on how to assess outcome in acute stroke trials. Cutoff scores for the Barthel Index (BI) and modified Rankin Scale (mRS) are frequently arbitrarily chosen to dichotomize favorable and unfavorable outcome. We investigated sensitivity and specificity of BI cutoff scores in relation to the mRS to obtain the optimal corresponding BI and mRS scores. Methods— BI and mRS scores were collected from 1034 ischemic stroke patients. Sensitivity and specificity were calculated for BI cutoff scores from 45 to 100 in mRS score 1, 2, and 3 and were plotted in receiver operator characteristic (ROC) curves. Results— The cutoff scores for the BI with the highest sum of sensitivity and specificity were 95 (sensitivity 85.6%; specificity 91.7%), 90 (sensitivity 90.7%; specificity 88.1%), and 75 (sensitivity 95.7%; specificity, 88.5%) for, respectively, mRS 1, 2, and 3. The area under the ROC curve was 0.933 in mRS 1, 0.960 in mRS 2, and 0.979 in mRS 3. Conclusions— The optimal cutoff scores for the BI were 95 for mRS 1, 90 for mRS 2, and 75 for mRS 3. For future acute stroke trials that assess stroke outcome with the BI and mRS, we recommend the use of these BI cutoff score(s) with the corresponding mRS cutoff score(s), to ensure the use of consistent and uniform end points.Keywords
This publication has 13 references indexed in Scilit:
- The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)Stroke, 2005
- Measuring Outcomes as a Function of Baseline Severity of Ischemic StrokeCerebrovascular Diseases, 2004
- Disability Measures in StrokeStroke, 2004
- Strengthening Acute Stroke Trials Through Optimal Use of Disability End PointsStroke, 2003
- Assessment of Functioning and Disability After Ischemic StrokeStroke, 2002
- Could Stroke Trials Be Missing Important Treatment Effects?Cerebrovascular Diseases, 2002
- Defining post-stroke recovery: implications for design and interpretation of drug trialsNeuropharmacology, 2000
- Multinational Randomised Controlled Trial of Lubeluzole in Acute Ischaemic StrokeCerebrovascular Diseases, 1998
- Dichotomizing stroke outcomes based on self-reported dependencyNeurology, 1997
- A Comparison of the Barthel Index and the OPCS Disability Instrument used to Measure Outcome after Acute StrokeAge and Ageing, 1995